Adiposopathy: why do adiposity and obesity cause metabolic disease?

被引:49
作者
Bays, Harold
Ballantyne, Christie
机构
[1] LMARC Res Ctr, Louisville, KY 40213 USA
[2] Baylor Coll Med, Ctr Cardiovasc Dis Prevent, Houston, TX 77030 USA
来源
FUTURE LIPIDOLOGY | 2006年 / 1卷 / 04期
关键词
adiposity; adiposopathy; diabetes; dyslipidemia; hypertension; obesity;
D O I
10.2217/17460875.1.4.389
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the adipocentric paradigm, fat health affects patient health. Adiposopathy ('pathos' of adipose tissue or fat dysfunction) is more directly associated with excessive fat-related metabolic disease (EFRMD) than adiposity (increased fat mass) alone. Examples of adipocyte factors whose dysmetabolism may contribute to Type 2 diabetes mellitus include: 11 beta-hydroxysterold dehydrogenase type 1, acylation-stimulating protein, adiponectin, adipsin, anglotensinogen, autotaxin, ceramide, free fatty acids, hormone-sensitive lipase, interieukin-6, insulin-like growth factor-1, leptin, lipin, lysophospholipids, perillpin, phosphoenolpyrovate carboxykinase, plasminogen activator inhibitor-1, resistin, retinol-bincling protein, tumor necrosis factor-a, visceral adipose tissue-derived serpin and visfatin. Excessive body fat may lead to hypertension due to physical compression of kidneys, sleep apnea, and other mechanisms. Examples of adipocyte factors whose dysmetabolism may contribute to hypertension include: 11 beta-hydroxysteroid dehydrogenase type 1, adiponectin, angiotensinogen, anglotensin I and II, angiotensin-converting enzyme, renin, cathepsin, chymase, free fatty acids, interleukin-6 and leptin. Examples of adipocyte factors whose dysmetabolism may contribute to dyslipidemia include: 11 beta-hydroxysterold dehydrogenase type 1, acylation-stimulating protein, adipophilin, adiponectin, adipsin, cholesteryl ester-transfer protein, free fatty acids, hormone-sensitive lipase, leptin, lipoprotein lipase, perilipin, phosphollpid transfer protein, sex hormones and tumor necrosis factor-a. Numerous other adipocyte factors may directly affect atherosclerosis and cardiomyopathy, A better understanding and recognition of how fat weight gain contributes to EFRMD will substantially affect the research and development of therapeutic interventions that may treat or prevent adiposopathy, and dramatically influence which patients with EFRMD are best treated and how.
引用
收藏
页码:389 / 420
页数:32
相关论文
共 243 条
  • [1] EPIDERMAL GROWTH-FACTOR PROMOTES ADIPOGENESIS OF 3T3-L1 CELL IN-VITRO
    ADACHI, H
    KURACHI, H
    HOMMA, H
    ADACHI, K
    IMAI, T
    MORISHIGE, KI
    MATSUZAWA, Y
    MIYAKE, A
    [J]. ENDOCRINOLOGY, 1994, 135 (05) : 1824 - 1830
  • [2] Acylation stimulating protein stimulates insulin secretion
    Ahrén, B
    Havel, PJ
    Pacini, G
    Cianflone, K
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (09) : 1037 - 1043
  • [3] Alpert Martin A, 2005, Expert Rev Cardiovasc Ther, V3, P225, DOI 10.1586/14779072.3.2.225
  • [4] The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: Influence of gender and site
    Anderson, LA
    McTernan, PG
    Barnett, AH
    Kumar, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) : 5045 - 5051
  • [5] Hypertension and obesity
    Aneja, A
    El-Atat, F
    McFarlane, S
    Sowers, JR
    [J]. RECENT PROGRESS IN HORMONE RESEARCH, VOL 59: CARDIOVASCULAR ENDOCRINOLOGY & OBESITY, 2004, 59 : 169 - 205
  • [6] Journey from cachexia to obesity by TNF
    Argiles, JM
    LopezSoriano, J
    Busquets, S
    LopezSoriano, FJ
    [J]. FASEB JOURNAL, 1997, 11 (10) : 743 - 751
  • [7] Arner P, 2001, BIOCHEM SOC T, V29, P72, DOI 10.1042/bst0290072
  • [8] Increased serum cholesteryl ester transfer protein in obese children
    Asayama, K
    Hayashibe, H
    Dobashi, K
    Uchida, N
    Nakane, T
    Kodera, K
    Shirahata, A
    [J]. OBESITY RESEARCH, 2002, 10 (06): : 439 - 446
  • [9] Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x
  • [10] Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease
    Baker, Adam R.
    da Silva, Nancy F.
    Quinn, David W.
    Harte, Alison L.
    Pagano, Domenico
    Bonser, Robert S.
    Kumar, Sudhesh
    McTernan, Philip G.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2006, 5 (1)